Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer.
Hiroaki IwamotoKouji IzumiTomoyuki MakinoAtsushi MizokamiPublished in: Cancers (2022)
The recommended treatment for high-risk localized or locally advanced prostate cancer is radical prostatectomy plus extended pelvic lymph node dissection or radiation therapy plus long-term androgen deprivation therapy. However, some patients are treated with androgen deprivation therapy alone for various reasons. In this review, we will discuss the position, indications, complications, and future prospects of androgen deprivation therapy for high-risk localized and locally advanced prostate cancer.
Keyphrases
- radical prostatectomy
- prostate cancer
- locally advanced
- rectal cancer
- radiation therapy
- neoadjuvant chemotherapy
- squamous cell carcinoma
- phase ii study
- newly diagnosed
- current status
- ejection fraction
- clinical trial
- early stage
- lymph node
- risk factors
- prognostic factors
- combination therapy
- bone marrow
- replacement therapy
- study protocol
- radiation induced